Streptococcus thermophilus derived human CXCR3 gene target sequence recognizable by CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9 (CRISPR associated 9) system and sgRNA (single guide ribonucleic acid) and application thereof
A technology for identifying sequences and systems, applied in the field of genetic engineering, can solve the problems of frameshift mutation, DNA insertion or deletion, low efficiency, etc., and achieve the effect of preventing and/or treating AIDS
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] This example is used to illustrate the design of the sgRNA of the present invention.
[0043] According to the 5'-recognition sequence-recruiting Cas9 protein sequence-3' and the base sequence shown in Table 1 below, 992 sgRNAs were constructed.
[0044] Table 1
[0045]
[0046]
[0047]
Embodiment 2
[0049] This example is used to illustrate the construction of the CRISPR-Cas9 system of the present invention.
[0050] (1) Add CACC to the 5'end of the DNA sequence corresponding to the sgRNA (as shown in Example 1) to obtain a forward oligonucleotide (Forwardoligo). According to this sgRNA, obtain its complementary strand and place it at its 5'end Add AAAC to get Reverseoligo. Synthesize separately. If the first base at the 5'end of the DNA sequence corresponding to the sgRNA recognition sequence is not a G, a G must be added after CACC, and a matching C must be added to the 3'end of the reverse oligonucleotide. The above-mentioned forward oligonucleotide and reverse oligonucleotide are denatured and annealed in pairs. After annealing, a double-stranded sgRNA oligonucleotide that can be connected to the U6 eukaryotic expression vector is formed. The denaturation and annealing system is:
[0051]
[0052]
[0053] The PCR conditions are: 37°C for 30 minutes; 95°C for 5 minutes; ...
Embodiment 3
[0069] This example is used to illustrate the method of editing CXCR4 gene using the CRISPR-Cas9 system of the present invention.
[0070] (1) Cell culture and transfection
[0071] (1) HEK293T cells (CBR-130005, purchased from Shanghai Saiqi Biological Engineering Co., Ltd.) in DMEM high glucose medium (containing 10% FBS, penicillin (penicillin, 100U / ml) and streptomycin (100μg) / ml)) culture;
[0072] (2) Divide into a six-well plate before transfection, and perform transfection when the cell density reaches 70%;
[0073] (3) Use 3μg of U6-hCXCR4sgRNA-EF1a-NLS-StCas9-NLS-2A-Puro-WPRE or 1.5μg of U6-hCXCR4sgRNA-EF1a-Neo-WPRE according to the dosage ratio of Lipofectamine3000 (Invitrogen, 11668-019) 1.5μg of U6-EF1a-NLS-StCas9-NLS-2A-Puro-WPRE combination transfected cells per well, 8h later, the medium was changed, correspondingly, puromycin (Puromycin) and G418 (Geneticin) were added for drug screening, 48h After collecting the cells.
[0074] (2) TA clone sequencing detection:
[...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com